https://www.selleckchem.com/products/oltipraz.html
This review describes a presentation at a recent symposium entitled "SUs in the treatment of T2DM a fresh look and new insights" on Wednesday September 18, 2019 at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. It examines the current role of sulfonylureas (SUs) in the management of type 2 diabetes mellitus (T2DM) and gives the author's personal perspective of how this therapeutic class has performed in both local and international guidelines. The place of SUs within current gu
Me gusta
Comentario
Compartir
